Biotech · Private company
Constellation Pharmaceuticals
Track this companyFree. Adds Constellation Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- AbirateronePhase 2 · Metastatic Castration Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- CobicistatPhase 2 · Metastatic Castration Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- CPI-1205Phase 2 · Metastatic Castration Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- EnzalutamidePhase 2 · Metastatic Castration Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- PelabresibPhase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
- PrednisonePhase 2 · Metastatic Castration Resistant Prostate Cancer (mCRPC)ClinicalTrials.gov · fetched Nov 12, 2026
- RuxolitinibPhase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
- CPI-1205Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CPI-1205Phase 1 · B-Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- ipilimumabPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- PelabresibPhase 1 · Advanced MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Study Evaluating Food Effect and QTc in Patients With Advanced MalignanciesPHASE1 · COMPLETED · started Jul 20, 2021ClinicalTrials.gov NCT05391022 · fetched Nov 12, 2026
- ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Dec 14, 2017ClinicalTrials.gov NCT03525795 · fetched Nov 12, 2026
- ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate CancerPHASE1_PHASE2 · COMPLETED · started Nov 15, 2017ClinicalTrials.gov NCT03480646 · fetched Nov 12, 2026
- A Study Evaluating CPI-1205 in Patients With B-Cell LymphomasPHASE1 · COMPLETED · started Mar 1, 2015ClinicalTrials.gov NCT02395601 · fetched Nov 12, 2026
- A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative MalignanciesPHASE1_PHASE2 · COMPLETED · started Jul 16, 2014ClinicalTrials.gov NCT02158858 · fetched Nov 12, 2026